Previous 10 | Next 10 |
Search all articles related articles and news articles from the OTCMKTS NASDAQ and NYSE markets.
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Tre...
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the looming June 11, 2024 deadline to seek t...
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Intel Corporation (NASDAQ:INTC)? Did you p...
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in t...
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in t...
Citigroup analyst Asiya Merchant maintained Amphenol Corp (NYSE:APH) with a Buy and raised the price target from $135 ...
Citigroup analyst Asiya Merchant maintained Amphenol Corp (NYSE:APH) with a Buy and raised the price target from $135 ...
Citigroup analyst Asiya Merchant maintained Amphenol Corp (NYSE:APH) with a Buy and raised the price target from $135 ...
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Equinix, Inc. (NASDAQ:EQIX) investors who suffered substantial losses to tak...
On Tuesday, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced that it will present Phase 1 results in healthy volunteers and new Pha...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
17.22%Change Percent:
Cellectar Biosciences Inc. Company Name:
CLRB Stock Symbol:
NASDAQ Market:
cellectar.com Website: